Literature DB >> 1845873

Molecular cloning of gp42, a cell-surface molecule that is selectively induced on rat natural killer cells by interleukin 2: glycolipid membrane anchoring and capacity for transmembrane signaling.

W E Seaman1, E C Niemi, M R Stark, R D Goldfien, A S Pollock, J B Imboden.   

Abstract

We have previously shown that in vitro culture of rat natural killer (NK) cells in high concentrations of recombinant interleukin 2 (rIL-2) leads to the expression of a surface glycoprotein with a molecular mass of approximately 42 kD. This glycoprotein, gp42, is not induced on other lymphocytes and thus provides a lineage-specific marker for rIL-2-activated NK cells. We here present the nucleotide sequence for gp42 cDNA. The open reading frame encodes 233 amino acids with three potential sites for N-linked glycosylation. The deduced amino acid sequence lacks an apparent transmembrane domain and instead contains a hydrophobic COOH terminus that is characteristic of glycosylphosphatidylinositol (GPI)-anchored surface proteins. Consistent with this, gp42 is cleaved from the NK-like cell line, RNK-16, by phosphatidylinositol-specific phospholipase C (PI-PLC), as is gp42 expressed on CHO cells that have been transformed with gp42 cDNA. On rIL-2-activated NK cells, gp42 is resistant to PI-PLC, though our studies suggest that gp42 on these cells is still expressed as a GPI-anchored molecule. Antibody to gp42 stimulates in RNK-16 cells an increase in inositol phosphates and in intracellular calciu, signals that are associated with the activation of lymphocytes, including NK cells. rIL-2-activated NK cells, however, lack this response to gp42 as well as to other stimuli. Thus, gp42, the only NK-specific activation antigen, is a GPI-anchored surface molecule with the capacity to stimulate transmembrane signaling.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1845873      PMCID: PMC2118766          DOI: 10.1084/jem.173.1.251

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  52 in total

1.  Isolation and expression of functional high-affinity Fc receptor complementary DNAs.

Authors:  J M Allen; B Seed
Journal:  Science       Date:  1989-01-20       Impact factor: 47.728

2.  Anti-Qa-2-induced T cell activation. The parameters of activation, the definition of mitogenic and nonmitogenic antibodies, and the differential effects on CD4+ vs CD8+ T cells.

Authors:  A B Hahn; M J Soloski
Journal:  J Immunol       Date:  1989-07-15       Impact factor: 5.422

3.  Generation of inositol phosphates during triggering of cytotoxicity in human natural killer and lymphokine-activated killer cells.

Authors:  A K Ståhls; O Carpén
Journal:  Scand J Immunol       Date:  1989-02       Impact factor: 3.487

4.  Identification and characterization of a cell-surface molecule that is selectively induced on rat lymphokine-activated killer cells.

Authors:  J B Imboden; E C Eriksson; M McCutcheon; C W Reynolds; W E Seaman
Journal:  J Immunol       Date:  1989-11-01       Impact factor: 5.422

5.  Structural characterization of the TAP molecule: a phosphatidylinositol-linked glycoprotein distinct from the T cell receptor/T3 complex and Thy-1.

Authors:  H Reiser; H Oettgen; E T Yeh; C Terhorst; M G Low; B Benacerraf; K L Rock
Journal:  Cell       Date:  1986-11-07       Impact factor: 41.582

6.  Fc gamma R(CD16) interaction with ligand induces Ca2+ mobilization and phosphoinositide turnover in human natural killer cells. Role of Ca2+ in Fc gamma R(CD16)-induced transcription and expression of lymphokine genes.

Authors:  M A Cassatella; I Anegón; M C Cuturi; P Griskey; G Trinchieri; B Perussia
Journal:  J Exp Med       Date:  1989-02-01       Impact factor: 14.307

7.  Activation of natural killer cells via the p75 interleukin 2 receptor.

Authors:  J H Phillips; T Takeshita; K Sugamura; L L Lanier
Journal:  J Exp Med       Date:  1989-07-01       Impact factor: 14.307

8.  Response of resting human peripheral blood natural killer cells to interleukin 2.

Authors:  G Trinchieri; M Matsumoto-Kobayashi; S C Clark; J Seehra; L London; B Perussia
Journal:  J Exp Med       Date:  1984-10-01       Impact factor: 14.307

9.  Alternative membrane forms of Fc gamma RIII(CD16) on human natural killer cells and neutrophils. Cell type-specific expression of two genes that differ in single nucleotide substitutions.

Authors:  J V Ravetch; B Perussia
Journal:  J Exp Med       Date:  1989-08-01       Impact factor: 14.307

10.  Interleukin 2 activation of natural killer cells rapidly induces the expression and phosphorylation of the Leu-23 activation antigen.

Authors:  L L Lanier; D W Buck; L Rhodes; A Ding; E Evans; C Barney; J H Phillips
Journal:  J Exp Med       Date:  1988-05-01       Impact factor: 14.307

View more
  6 in total

Review 1.  Emerging roles for the FCRL family members in lymphocyte biology and disease.

Authors:  F J Li; W J Won; E J Becker; J L Easlick; E M Tabengwa; R Li; M Shakhmatov; K Honjo; P D Burrows; R S Davis
Journal:  Curr Top Microbiol Immunol       Date:  2014       Impact factor: 4.291

2.  The OX-44 molecule couples to signaling pathways and is associated with CD2 on rat T lymphocytes and a natural killer cell line.

Authors:  G M Bell; W E Seaman; E C Niemi; J B Imboden
Journal:  J Exp Med       Date:  1992-02-01       Impact factor: 14.307

3.  p46, a novel natural killer cell-specific surface molecule that mediates cell activation.

Authors:  S Sivori; M Vitale; L Morelli; L Sanseverino; R Augugliaro; C Bottino; L Moretta; A Moretta
Journal:  J Exp Med       Date:  1997-10-06       Impact factor: 14.307

4.  New nucleotide sequence data on the EMBL File Server.

Authors: 
Journal:  Nucleic Acids Res       Date:  1991-07-11       Impact factor: 16.971

5.  NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis.

Authors:  M Vitale; C Bottino; S Sivori; L Sanseverino; R Castriconi; E Marcenaro; R Augugliaro; L Moretta; A Moretta
Journal:  J Exp Med       Date:  1998-06-15       Impact factor: 14.307

6.  Fc Receptor-Like Proteins in Pathophysiology of B-cell Disorder.

Authors:  Mollie Capone; John Matthew Bryant; Natalie Sutkowski; Azizul Haque
Journal:  J Clin Cell Immunol       Date:  2016-06-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.